Geng M, Lin A, Nguyen T
Front Pharmacol. 2020; 11:581837.
PMID: 33240090
PMC: 7680856.
DOI: 10.3389/fphar.2020.581837.
Valembois L, Audureau E, Takeda A, Jarzebowski W, Belmin J, Lafuente-Lafuente C
Cochrane Database Syst Rev. 2019; 9:CD005049.
PMID: 31483500
PMC: 6738133.
DOI: 10.1002/14651858.CD005049.pub5.
Nichol G, McAlister F, Pham B, Laupacis A, Shea B, Green M
Heart. 2002; 87(6):535-43.
PMID: 12010934
PMC: 1767130.
DOI: 10.1136/heart.87.6.535.
Crijns H, Gosselink A, Lie K
Cardiovasc Drugs Ther. 1996; 10(2):145-52.
PMID: 8842506
DOI: 10.1007/BF00823592.
Nattel S, Hadjis T, Talajic M
Drugs. 1994; 48(3):345-71.
PMID: 7527757
DOI: 10.2165/00003495-199448030-00003.
Plasma concentration of disopyramide given as capsules and controlled release tablets.
Arnman K, Graffner C, Rikner L, Ryden L, Voog L
Eur J Clin Pharmacol. 1983; 24(2):199-203.
PMID: 6840167
DOI: 10.1007/BF00613817.
Efficacy of disopyramide in conversion and prophylaxis of post-thyrotoxic atrial fibrillation.
Nakazawa H, Ishikawa N, Noh J, Sugimoto T, Yoshimoto M, Yashiro T
Eur J Clin Pharmacol. 1991; 40(3):215-9.
PMID: 2060555
DOI: 10.1007/BF00315198.
Antiarrhythmic drug classifications. A critical appraisal of their history, present status, and clinical relevance.
Nattel S
Drugs. 1991; 41(5):672-701.
PMID: 1712704
DOI: 10.2165/00003495-199141050-00002.
The pharmacologic treatment of atrial fibrillation.
Bolognesi R
Cardiovasc Drugs Ther. 1991; 5(3):617-28.
PMID: 1678964
DOI: 10.1007/BF03029730.
Pharmacodynamics of the antiarrhythmic disopyramide in healthy humans: correlation of the kinetics of the drug and its effects.
Hinderling P, GARRETT E
J Pharmacokinet Biopharm. 1976; 4(3):231-42.
PMID: 978390
DOI: 10.1007/BF01063615.
Pharmacokinetics of the antiarrhythmic disopyramide in healthy humans.
Hinderling P, GARRETT E
J Pharmacokinet Biopharm. 1976; 4(3):199-230.
PMID: 978389
DOI: 10.1007/BF01063614.
Disopyramide serum and pharmacologic effect kinetics applied to the assessment of bioavailability.
Bryson S, Whiting B, Lawrence J
Br J Clin Pharmacol. 1978; 6(5):409-19.
PMID: 728284
PMC: 1429565.
DOI: 10.1111/j.1365-2125.1978.tb04605.x.
Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.
Anderson J, Harrison D, Meffin P, Winkle R
Drugs. 1978; 15(4):271-309.
PMID: 648399
DOI: 10.2165/00003495-197815040-00003.
Effects of disopyramide on electrophysiological properties of specialized conduction system in man and on accessory atrioventricular pathway in Wolff-Parkinson-White syndrome.
Spurrell R, Thorburn C, Camm J, Sowton E, DEUCHAR D
Br Heart J. 1975; 37(8):861-7.
PMID: 53057
PMC: 482887.
DOI: 10.1136/hrt.37.8.861.
